Entrada Therapeutics (TRDA) Selling, General & Administrative (2020 - 2026)
Powered by 
Analysis
Entrada Therapeutics (TRDA) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Entrada Therapeutics | 300.62 Mn | 300.62 Mn | - | 10.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.49 Mn |
| Mar 31, 2026 | 10.12 Mn |
| Dec 31, 2025 | 9.55 Mn |
| Sep 30, 2025 | 10.30 Mn |
| Jun 30, 2025 | 10.92 Mn |
| Mar 31, 2025 | 10.27 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Sep 30, 2024 | 9.97 Mn |
| Jun 30, 2024 | 9.24 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Dec 31, 2023 | 8.65 Mn |
| Sep 30, 2023 | 7.53 Mn |
| Jun 30, 2023 | 8.17 Mn |
| Mar 31, 2023 | 7.94 Mn |
| Dec 31, 2022 | 9.89 Mn |
| Sep 30, 2022 | 6.98 Mn |
| Jun 30, 2022 | 7.33 Mn |
| Mar 31, 2022 | 6.43 Mn |
| Dec 31, 2021 | 6.10 Mn |
| Sep 30, 2021 | 3.85 Mn |